GlassScriptPhysician profile
Scott W Birch
NPI 1760419550
$7,376.90
in general payments reported to CMS, 2019-2025
42 companies · $1,151 in 2025
The $1,151 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $883 · 2021: $1,177 · 2022: $1,405 · 2023: $1,282 · 2024: $1,140 · 2025: $1,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,572.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,486.18 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $1,072.15 | 2019-2025 | Ubrelvy, Vraylar, Qulipta |
| Pfizer INC. | $786.48 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $534.48 | 2019-2025 | Fasenra, Airsupra, Bevespi Aerosphere |
| Boehringer Ingelheim Pharmaceuticals, INC. | $442.39 | 2021-2025 | Ofev, Jascayd |
| Regeneron Healthcare Solutions, INC. | $416.26 | 2019-2025 | Dupixent |
| Abbott Laboratories | $366.52 | 2020-2024 | Freestyle Libre |
| Novo Nordisk INC | $269.68 | 2019-2022 | |
| Grifols USA, LLC | $231.79 | 2023-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $198.76 | 2024-2025 | |
| United Therapeutics Corporation | $162.29 | 2023-2025 | Tyvaso, Tyvaso |
| Allergan, INC. | $156.13 | 2020 | |
| Csl Behring | $140.54 | 2023-2025 | Kcentra |
| Amgen INC. | $108.28 | 2019-2025 | Otezla, Repatha, Evenity |
| Dexcom, INC. | $106.68 | 2021-2025 | Dexcom G6 Transmitter |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Birch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.